|
2024
|
Invention
|
Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses ther... |
|
|
Invention
|
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses the... |
|
2016
|
Invention
|
Controlled release formulations of levodopa and uses thereof. A modified release levodopa dosage ... |
|
2015
|
Invention
|
Controlled release formulations of levodopa and uses thereof. The current invention provides a co... |
|
|
G/S
|
pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmac... |
|
2014
|
Invention
|
Rapidly disintegrating formulations and methods thereof.
The invention relates to a rapidly disi... |
|
2009
|
G/S
|
Medical auto-injectors and syringes containing epinephrine for treatment of anaphylactic reaction... |
|
2005
|
Invention
|
Pharmaceutical dosage forms having immediate release and/or controlled release properties. The pr... |
|
2002
|
Invention
|
Press coated, pulsatile drug delivery system suitable for oral administration. A press-coated tab... |
|
2000
|
Invention
|
Stabilized pharmaceutical compositions containing bupropion hydrochloride. This invention is dire... |
|
1998
|
Invention
|
Multiplex drug delivery system suitable for oral administration. A multiplex drug delivery system... |
